Pam Taylor is an antitrust lawyer with more than 20 years of experience in antitrust and competition law issues, including the antitrust aspects of mergers, joint ventures, and government investigations. She represents clients in government antitrust investigations and enforcement actions before the Federal Trade Commission and the Department of Justice Antitrust Division. She also advises companies on Hart-Scott-Rodino premerger notification requirements, strategic alliances, pricing and price discrimination, marketing practices, distribution issues, dealer terminations, and Hatch-Waxman Act strategies.
Pam has provided antitrust advice to global companies on their distribution strategies for the United States.
Pam's recent representations include serving as antitrust counsel to Baxter International in its acquisition of Claris Injectables and to Baxalta in its $32 billion merger with Shire. Other representative clients include Abbott Laboratories, Boehringer Ingelheim, Cardinal Health, Hill-Rom, Infant Formula Council of the Americas, Veolia Environnement, and Zekelman Industries. Pam also has served as antitrust counsel to trade associations and counseled trade associations and members on standard-setting activities.
Pam is a member of the Illinois bar and serves on the board of the Legal Aid Society.
Attorney-Client Privilege and Common Interest Privilege in Antitrust Merger Review, The M&A Lawyer, Vol. 24, Issue 9
What You Need to Know About the New FTC DOJ Vertical Merger Guidelines, The M&A Lawyer, Volume 24, Issue 2
- Boston University (J.D. 1990); Wellesley College (A.B in English cum laude 1987)
- Illinois and Massachusetts
- Staff Attorney, Mergers I Division, Federal Trade Commission (1994-1999)
- Recognized by Chambers USA for antitrust (2013-2017)